AccuStem Sciences, Inc. (ACUT)
OTCMKTS
· Delayed Price · Currency is USD
0.474
0.00 (0.00%)
At close: Jan 17, 2025
AccuStem Sciences Employees
AccuStem Sciences had 3 employees as of December 31, 2023. The number of employees decreased by 1 or -25.00% compared to the previous year.
Employees
3
Change (1Y)
-1
Growth (1Y)
-25.00%
Revenue / Employee
n/a
Profits / Employee
-$459,681
Market Cap
4.16M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3 | -1 | -25.00% |
| Dec 31, 2022 | 4 | 0 | - |
| Dec 31, 2021 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 2,931 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 413 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 109 |
| SANUWAVE Health | 31 |
AccuStem Sciences News
- 19 days ago - AccuStem Sciences, Inc. Announces Chairman Purchase of Shares - GlobeNewsWire
- 1 year ago - AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership - GlobeNewsWire
- 1 year ago - AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer - GlobeNewsWire
- 1 year ago - Goldman Small Cap Research Publishes New Research Report on AccuStem Sciences, Inc. - Accesswire
- 1 year ago - AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals - GlobeNewsWire
- 1 year ago - AccuStem Announce Strategic Clinical and Operational Partnership - GlobeNewsWire
- 1 year ago - AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer - GlobeNewsWire
- 2 years ago - AccuStem Sciences, Inc. Announces Chairman Purchase of Shares - GlobeNewsWire